Systemic and myocardial inflammation in traditional and off-pump cardiac surgery

Texas Heart Institute Journal

Volumn 34, Issue 2, 2007, Pages 160-165

  Orhan, Gokcen ^a,b   Sargin, Murat ^a   Senay, Sahin ^a   Yuksel, Meral ^a   Kurc, Erol ^a   Tasdemir, Muge ^a   Ozay, Batuhan ^a   Aka, Serap Aykut ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Biological markers blood; Cardiopulmonary bypass adverse effects; Coronary artery bypass, off pump; Coronary artery bypass methods; Cytokines blood; Free radicals; Inflammation etiology prevention control; Myocardial reperfusion injury; Oxidants blood

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; HYDROGEN PEROXIDE; HYDROXYL GROUP; HYPOCHLORITE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CLINICAL ARTICLE; FEMALE; HEART; HEART VENTRICLE SEPTUM RUPTURE; HUMAN; HUMAN TISSUE; MALE; MYOCARDITIS; OFF PUMP CORONARY SURGERY; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; VENOUS BLOOD;

CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; CREATINE KINASE, MB FORM; FEMALE; HUMANS; INFLAMMATION; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDITIS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RESEARCH DESIGN; RESPIRATION, ARTIFICIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TROPONIN I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34447498781     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Penttila HJ, Lepojarvi MV, Kiviluoma KT, Kuakoranta PK, Hassinen IE, Peuhkurinen KF. Myocardial preservation during coronary surgery with and without cardiopulmonary bypass. Ann Thorac Surg 2001;71:565-71.
2. Gundry SR, Romano MA, Shattuck OH, Razzouk AJ, Bailey LL. Seven-year follow-up of coronary artery bypasses performed with and without cardiopulmonary bypass. J Thorac Cardiovasc Surg 1998;115:1273-8.
3. Matata BM, Sosnowski AW, Galinanes M. Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. Ann Thorac Surg 2000;69:785-91.
4. Alwan K, Falcoz PE, Alwan J, Mouawad W, Oujaimi G, Chocron S, Etievent JP. Beating versus arrested heart coronary revascularization: evaluation by cardiac troponin I release. Ann Thorac Surg 2004;77:2051-5.
5. Misoph M, Babin-Ebell J. Interindividual variations in cytokine levels following cardiopulmonary bypass. Heart Vessels 1997;12:119-27.
6. Liebold A, Keyl C, Birnbaum DE. The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass. Eur J Cardiothorac Surg 1999;15:340-5.
7. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845-57.
8. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 1993;7:563-73.
9. Pattwell D, Ashton T, McArdle A, Griffiths RD, Jackson MJ. Ischemia and reperfusion of skeletal muscle lead to the appearance of a stable lipid free radical in the circulation. Am J Physiol Heart Circ Physiol 2003;284:H2400-4.
10. Kontos HA. Oxygen radicals in cerebral ischemia: the 2001 Willis lecture. Stroke 2001;32:2712-6.
11. Larmann J, Theilmeier G. Inflammatory response to cardi ac surgery: cardiopulmonary bypass versus non-cardiopulmonary bypass surgery. Best Pract Res Clin Anaesthesiol 2004;18:425-38.
12. Wan IY, Arifi AA, Wan S, Yip JH, Sihoe AD, Thung KH, et al. Beating heart revascularization with or without cardiopulmonary bypass: evaluation of inflammatory response in a prospective randomized study. J Thorac Cardiovasc Surg 2004;127:1624-31.
13. Repine JE, Parsons PE. Oxidant-antioxidant balance in endotoxin-induced oxidative injury and tolerance to oxidative injury. In: Brigham KL, editor. Endotoxin and the lungs. New York: Marcel Dekker, Inc.; 1994. p. 207-27.
14. Simmonds NJ, Allen RE, Stevens TR, Van Someren RN, Blake DR, Rampton DS. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992;103:186-96.
15. Sabik JF, Gillinov AM, Blackstone EH, Vacha C, Houghtaling PL, Navia J, et al. Does off-pump coronary surgery reduce morbidity and mortality? J Thorac Cardiovasc Surg 2002;124:698-707.
16. Pawliczak R. The role of radical oxygen species in airway inflammation [in Polish]. Pol Merkur Lekarski 2003;14:493-6.
17. Butler J, Baigrie RJ, Parker D, Chong JL, Shale DJ, Pillai R, et al. Systemic inflammatory responses to cardiopulmonary bypass: a pilot study of the effects of pentoxifylline. Respir Med 1993;87:285-8.
18. Edmunds LH Jr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998;66(5 Suppl):S12-6; discussion S25-8.
19. Peivandi AA, Hake U, Dahm M, Opfermann UT, Peetz D, Hafner G, et al. Coronary revascularization: off-pump versus on-pump - a comparison of behavior of biochemical cardiac ischemia markers [in German]. Z Kardiol 2002;91:203-11.
20. Krejca M, Skiba J, Szmagala P, Gburek T, Bochenek A. Cardiac troponin T release during coronary surgery using intermittent cross-clamp with fibrillation, on-pump and offpump beating heart. Eur J Cardiothorac Surg 1999;16:337-41.
21. Bonchek LI. Off-pump coronary bypass: Is it for everyone? J Thorac Cardiovasc Surg 2002;124:431-4.
22. Menasche P. The systemic factor: the comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery. Ann Thorac Surg 2001;72:S2260-70.